Another successful year for the Glasgow Molecular Pathology Node
Published: 12 January 2018
Over the past 12 months the Glasgow Molecular Pathology (GMP) Node has continued to make good progress towards addressing the three priorities identified by the MRC in developing molecular pathology for the future: ‘path, proximity and people’.
Over the past 12 months the Glasgow Molecular Pathology (GMP) Node has continued to make good progress towards addressing the three priorities identified by the MRC in developing molecular pathology for the future: ‘path, proximity and people’.
Capacity underpinning the research workstrands has grown with staff embedded within NHS Greater Glasgow & Clyde, including: pathology, genetics and biorepository; informatics (NHSGGC Safe-HAVEN and University); and expertise in polyomics and health economics. The Masters in Molecular Pathology is established and is building expertise and a workforce that is capable of developing, undertaking, interpreting and applying the results of novel molecular diagnostics.
Glasgow’s unique infrastructure provides ‘proximity’ which has been strengthened by GMP through the establishment of a management and governance structure, driving enhanced working relationships between academic, clinical, pathology, biomedical staff and industry. Additionally, GMP has established a series of partnering events (Promoting Partnerships) focussed specifically on identifying collaborative opportunities across stakeholders. GMP has strong engagement with, and ‘buy-in’ from, NHS pathology and laboratory genetics allowing close working with academic and industry partners.
Additionally our cultural proximity enables the ‘paths’ for enhanced delivery and development. A pipeline of research projects, aimed at developing novel diagnostics for cancer, cardiovascular and inflammatory disease has been established and will utilise these ‘paths’.
Download the full highlights report Node highlights report
First published: 12 January 2018